I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| hepatocyte | 4 studies | 64% ± 25% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| hepatocyte | 4 studies | 64% ± 25% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| liver | 3 studies | 35% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 97814.95 | 226 / 226 | 98% | 2210.84 | 398 / 406 |
| prostate | 74% | 414.65 | 181 / 245 | 74% | 90.90 | 369 / 502 |
| lung | 84% | 138.77 | 488 / 578 | 38% | 13.59 | 442 / 1155 |
| stomach | 78% | 278.34 | 280 / 359 | 26% | 8.49 | 73 / 286 |
| spleen | 88% | 200.80 | 212 / 241 | 0% | 0 | 0 / 0 |
| adrenal gland | 80% | 80.25 | 207 / 258 | 5% | 2.18 | 11 / 230 |
| peripheral blood | 81% | 224.94 | 754 / 929 | 0% | 0 | 0 / 0 |
| breast | 42% | 59.07 | 195 / 459 | 23% | 18.29 | 262 / 1118 |
| lymph node | 0% | 0 | 0 / 0 | 45% | 30.62 | 13 / 29 |
| adipose | 45% | 67.43 | 539 / 1204 | 0% | 0 | 0 / 0 |
| pancreas | 29% | 23.13 | 96 / 328 | 14% | 1.92 | 25 / 178 |
| intestine | 18% | 6.49 | 171 / 966 | 15% | 13.03 | 78 / 527 |
| uterus | 22% | 6.76 | 38 / 170 | 8% | 1.93 | 36 / 459 |
| esophagus | 12% | 6.26 | 178 / 1445 | 15% | 11.84 | 28 / 183 |
| bladder | 19% | 4.33 | 4 / 21 | 6% | 2.43 | 31 / 504 |
| ovary | 14% | 4.03 | 26 / 180 | 6% | 1.30 | 25 / 430 |
| thymus | 18% | 6.40 | 118 / 653 | 2% | 1.61 | 10 / 605 |
| blood vessel | 14% | 6.65 | 183 / 1335 | 0% | 0 | 0 / 0 |
| heart | 12% | 5.44 | 106 / 861 | 0% | 0 | 0 / 0 |
| kidney | 9% | 1.85 | 8 / 89 | 1% | 3.67 | 12 / 901 |
| muscle | 10% | 3.31 | 81 / 803 | 0% | 0 | 0 / 0 |
| skin | 8% | 4.74 | 136 / 1809 | 2% | 0.37 | 10 / 472 |
| brain | 5% | 1.49 | 134 / 2642 | 1% | 0.22 | 8 / 705 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.45 | 1 / 45 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.07 | 1 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
| GO_0006953 | Biological process | acute-phase response |
| GO_0002682 | Biological process | regulation of immune system process |
| GO_0032732 | Biological process | positive regulation of interleukin-1 production |
| GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
| GO_0035578 | Cellular component | azurophil granule lumen |
| GO_0005615 | Cellular component | extracellular space |
| GO_0072562 | Cellular component | blood microparticle |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0031093 | Cellular component | platelet alpha granule lumen |
| GO_0005576 | Cellular component | extracellular region |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0035580 | Cellular component | specific granule lumen |
| Gene name | ORM2 |
| Protein name | Alpha-1-acid glycoprotein 2 (AGP 2) (Orosomucoid-2) (OMD 2) |
| Synonyms | AGP2 |
| Description | FUNCTION: Functions as a transport protein in the blood stream. Binds various hydrophobic ligands in the interior of its beta-barrel domain. Also binds synthetic drugs and influences their distribution and availability. Appears to function in modulating the activity of the immune system during the acute-phase reaction. . |
| Accessions | P19652 ENST00000431067.4 |
